Quantum molecular resonance electrotherapy (Rexon-Eye) for recalcitrant dry eye in an Asian population

Valencia Hui Xian Foo, Yu-Chi Liu, Bryan Tho, Louis Tong, Valencia Hui Xian Foo, Yu-Chi Liu, Bryan Tho, Louis Tong

Abstract

Objectives: To assess the safety, efficacy, patients' satisfaction and acceptability of Rexon-Eye electrotherapy in treating Asian severe dry eye disease (DED) patients.

Methods: Prospective parallel-arm pilot study recruiting 40 DED Chinese patients with >moderate recalcitrant DED (Contact Lens Research Unit [CCLRU] > grade 2). Subjects were randomized into 2 groups, undergoing four weekly treatment sessions each: group 1 received full treatment power; group 2 received control treatment (power 1 treatment). Non-invasive tear break-up time (NIBUT), cornea fluorescein staining graded via CCLRU and Schirmer's I test were compared pre- and 2 months post-treatment. The SPEED and QUEST questionnaires that evaluated subjective symptoms and treatment satisfaction, respectively, at baseline and 2 weeks post-treatment were carried out. Tear cytokine levels in both groups were examined at 2 weeks post-treatment.

Results: The amount of improvement in post-treatment corneal staining in the inferior corneal zone was significant in Group 1 (p = 0.038) but not in Group 2 (p = 0.832). Group 1 eyes with worse baseline staining (total score >9.8) had a significantly greater reduction of corneal staining than those with better baseline staining (-11.7 ± 1.98 vs. -4.6 ± 2.89, p < 0.001). There were no other significant differences in NIBUT, Schirmer's 1 and cornea fluorescein staining grading within or between the groups.: Group 1 (n = 24) had improved subjective dryness scores compared to Group 2 (n = 16) (SPEED score: 6.38 + 4.16 vs. 10.0 + 6.36, p = 0.04). No significant differences were seen in 11 tear cytokine levels at 2 weeks post-treatment between the 2 groups.

Conclusion: In Asian DED patients treated with Rexon-Eye, inferior cornea staining showed significant improvement compared to placebo, and eyes with greater cornea staining at baseline achieved a greater improvement in staining. There were no other significant improvements in NIBUT and Schirmer's 1. Rexon-Eye also improved subjective DED scores in 41.7% of eyes without any adverse effects.

Keywords: clinical trial; dry eye; ocular disease; tear disorder; therapeutics.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2023 Foo, Liu, Tho and Tong.

References

    1. Craig J, Nichols K, Akpek E, Caffery B, Dua H, Joo C, et al. Definition and classification report. Ocul Surf. (2017) 15:276–83. 10.1016/j.jtos.2017.05.008
    1. Agarwal P, Craig J, Rupenthal I. Formulation considerations for the management of dry eye disease. Pharmaceutics. (2021) 13:207. 10.3390/pharmaceutics13020207
    1. O’Neil E, Henderson M, Massaro-Giordano M, Bunya V. Advances in dry eye disease treatment. Curr Opin Ophthalmol. (2019) 30:166. 10.1097/ICU.0000000000000569
    1. Shen Lee B, Toyos M, Karpecki P, Schiffbauer J, Sheppard J. Selective pharmacologic therapies for dry eye disease treatment: efficacy, tolerability, and safety data review from preclinical studies and pivotal trials. Ophthalmol Ther. (2022) 11:1333–69. 10.1007/s40123-022-00516-9
    1. Pedrotti E, Bosello F, Fasolo A, Frigo A, Marchesoni I, Ruggeri A, et al. Transcutaneous periorbital electrical stimulation in the treatment of dry eye. Br J Ophthalmol. (2017) 101:814–9. 10.1136/bjophthalmol-2016-308678
    1. Maschio M, Canato M, Pigozzo F. Biophysical effects of high frequency electrical field (4 MHz) on muscle fibers in culture. Basic Appl Myol. (2009) 19:49–56.
    1. Song B, Gu Y, Pu J, Reid B, Zhao Z, Zhao M. Application of direct current electric fields to cells and tissues in vitro and modulation of wound electric field in vivo. Nat Protoc. (2007) 2:1479–89. 10.1038/nprot.2007.205
    1. Haastert-Talini K, Grothe C. Electrical stimulation for promoting peripheral nerve regeneration. Int Rev Neurobiol. (2013) 109:111–24. 10.1016/B978-0-12-420045-6.00005-5
    1. Song B, Zhao M, Forrester J, McCaig C. Nerve regeneration and wound healing are stimulated and directed by an endogenous electrical field in vivo. J Cell Sci. (2004) 117:4681–90. 10.1242/jcs.01341
    1. Ghaffarieh A, Ghaffarpasand F, Dehghankhalili M, Honarpisheh N, Nirumandi S, Tanideh N. Effect of transcutaneous electrical stimulation on rabbit corneal epithelial cell migration. Cornea. (2012) 31:559–63. 10.1097/ICO.0b013e31823f8b2a
    1. Wenjin W, Wenchao L, Hao Z, Feng L, Yan W, Wodong S, et al. Electrical stimulation promotes BDNF expression in spinal cord neurons through Ca(2+)- and Erk-dependent signaling pathways. Cell Mol Neurobiol. (2011) 31:459–67. 10.1007/s10571-010-9639-0
    1. Sella S, Adami V, Amati E, Bernardi M, Chieregato K, Gatto P, et al. In-vitro analysis of quantum molecular resonance effects on human mesenchymal stromal cells. PLoS One. (2018) 13:e0190082. 10.1371/journal.pone.0190082
    1. Trivli A, Karmiris E, Dalianis G, Ruggeri A, Terzidou C. Evaluating the efficacy of quantum molecular resonance (QMR) electrotherapy in mixed-type dry eye patients. J Opt. (2022) 16:128–34. 10.1016/j.optom.2022.06.003
    1. Ferrari G, Colucci A, Barbariga M, Ruggeri A, Rama P. High frequency electrotherapy for the treatment of meibomian gland dysfunction. Cornea. (2019) 38:1424–9. 10.1097/ICO.0000000000002063
    1. Fraccalvieri M, Salomone M, Di Santo C, Ruka E, Morozzo U, Bruschi S. Quantum molecular resonance technology in hard-to-heal extremity wounds: histological and clinical results. Int Wound J. (2017) 14:1313–22. 10.1111/iwj.12805
    1. Trobinger V. Esperienza clinica nell’impiego del dispositivo Rexon-Age. (2009). Available online at: (accessed March 13, 2023).
    1. Lopresti M, Tomba A, Caserta A, Di Domenica F. Studio clinico sull’efficacia della risonanza quantica molecolare nel trattamento dell’edema post-chirurgico in pazienti sottoposti a intervento di artroprotesi di ginocchio. Arch Ortope Reumatol. (2011) 122:34–5. 10.1007/s10261-011-0013-7
    1. Terry R, Schnider C, Holden B, Cornish R, Grant T, Sweeney D, et al. CCLRU standards for success of daily and extended wear contact lenses. Opt Vis Sci. (1993) 70:234–43. 10.1097/00006324-199303000-00011
    1. Ngo W, Situ P, Keir N, Korb D, Blackie C, Simpson T. Psychometric properties and validation of the standard patient evaluation of eye dryness questionnaire. Cornea. (2013) 32:1204–10. 10.1097/ICO.0b013e318294b0c0
    1. Lee R, Yeo S, Aung H, Tong L. Agreement of noninvasive tear break-up time measurement between Tomey RT-7000 auto refractor-Keratometer and oculus Keratograph 5M. Clin Ophthalmol. (2016) 10:1785–90. 10.2147/OPTH.S110180
    1. Willems B, Tong L, Minh T, Pham N, Nguyen X, Zumbansen M. Novel cytokine multiplex assay for tear fluid analysis in Sjogren’s syndrome. Ocul Immunol Inflamm. (2021) 29:1639–44. 10.1080/09273948.2020.1767792
    1. Cai M, Zhang J. Effectiveness of transcutaneous electrical stimulation combined with artificial tears for the treatment of dry eye: a randomized controlled trial. Exp Ther Med. (2020) 20:175. 10.3892/etm.2020.9305
    1. Han G, Yoo Y, Shin E, Park J, Park Y, Kim P, et al. Transcutaneous electrical stimulation for the prevention of dry eye disease after photorefractive keratectomy: randomized controlled trial. Ophthalmol Sci. (2022) 3:100242. 10.1016/j.xops.2022.100242
    1. Sivanesan E, Levitt R, Sarantopoulos C, Patin D, Galor A. Noninvasive electrical stimulation for the treatment of chronic ocular pain and photophobia. Neuromodulation. (2018) 21:727–34. 10.1111/ner.12742
    1. Friedman N, Butron K, Robledo N, Loudin J, Baba S, Chayet A. A nonrandomized, open-label study to evaluate the effect of nasal stimulation on tear production in subjects with dry eye disease. Clin Ophthalmol. (2016) 10:795–804. 10.2147/OPTH.S101716
    1. Tong L, Beuerman R, Simonyi S, Hollander D, Stern M. Effects of punctal occlusion on clinical signs and symptoms and on tear cytokine levels in patients with dry eye. Ocul Surf. (2016) 14:233–41. 10.1016/j.jtos.2015.12.004
    1. Tong L, Wong T, Cheng C. Level of tear cytokines in population-level participants and correlation with clinical features. Cytokine. (2018) 110:452–8. 10.1016/j.cyto.2018.05.013
    1. Le Guezennec X, Quah J, Tong L, Kim N. Human tear analysis with miniaturized multiplex cytokine assay on “wall-less” 96-well plate. Mol Vis. (2015) 21:1151–61.
    1. Roda M, Corazza I, Bacchi Reggiani M, Pellegrini M, Taroni L, Giannaccare G, et al. Dry eye disease and tear cytokine levels-a meta-analysis. Int J Mol Sci. (2020) 21:3111. 10.3390/ijms21093111
    1. Yamaguchi T. Inflammatory response in dry eye. Invest Ophthalmol Vis Sci. (2018) 59:DES192–9. 10.1167/iovs.17-23651
    1. Periman L, Mah F, Karpecki PMA. Review of the mechanism of action of cyclosporine a: the role of cyclosporine a in dry eye disease and recent formulation developments. Clin Ophthalmol. (2020) 14:4187–200. 10.2147/OPTH.S279051
    1. Lee J, Min K, Kim S, Kim E, Kim T. Inflammatory cytokine and osmolarity changes in the tears of dry eye patients treated with topical 1% methylprednisolone. Yonsei Med J. (2014) 55:203–8. 10.3349/ymj.2014.55.1.203
    1. Stump R, Robinson K. Xenopus neural crest cell migration in an applied electrical field. J Cell Biol. (1983) 97:1226–33. 10.1083/jcb.97.4.1226
    1. Zhao M, Penninger J, Isseroff R. Electrical activation of wound-healing pathways. Adv Skin Wound Care. (2010) 1:567–73.
    1. Nuccitelli R, Erickson C. Embryonic cell motility can be guided by physiological electric fields. Exp Cell Res. (1983) 147:195–210. 10.1016/0014-4827(83)90284-7
    1. Erickson C, Nuccitelli R. Embryonic fibroblast motility and orientation can be influenced by physiological electric fields. J Cell Biol. (1984) 98:296–307. 10.1083/jcb.98.1.296
    1. Hinkle L, McCaig C, Robinson K. The direction of growth of differentiating neurones and myoblasts from frog embryos in an applied electric field. J Physiol. (1981) 314:121–35. 10.1113/jphysiol.1981.sp013695
    1. Jaffe L, Poo M. Neurites grow faster towards the cathode than the anode in a steady field. J Exp Zool. (1979) 209:115–28. 10.1002/jez.1402090114
    1. Soong H, Parkinson W, Bafna S, Sulik G, Huang S. Movements of cultured corneal epithelial cells and stromal fibroblasts in electric fields. Invest Ophthalmol Vis Sci. (1990) 31:2278–82.
    1. Zhao M, Agius-Fernandez A, Forrester J, McCaig C. Orientation and directed migration of cultured corneal epithelial cells in small electric fields areserum dependent. J Cell Sci. (1996) 109:1405–14. 10.1242/jcs.109.6.1405

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever